EFFECT ON RENIN RELEASE OF INHIBITING RENAL NITRIC-OXIDE SYNTHESIS IN ANESTHETIZED DOGS

被引:35
|
作者
NAESS, PA
CHRISTENSEN, G
KIRKEBOEN, KA
KIIL, F
机构
[1] University of Oslo, Institute for Experimental Medical Research, Ulleval Hospital, Oslo
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1993年 / 148卷 / 02期
关键词
ENDOTHELIUM-DERIVED RELAXING FACTOR; N(G)-NITRO-L-ARGININE; NITRIC OXIDE; RENAL ARTERIAL CONSTRICTION; RENIN RELEASE;
D O I
10.1111/j.1748-1716.1993.tb09543.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Nitric oxide plays an important role in the regulation of basal renal blood flow. This study was performed to examine whether selective inhibition of renal nitric oxide synthesis affects renin release in vivo. Accordingly, in six barbiturate-anaesthetized dogs renin release was examined before and after intrarenal infusion of the selective inhibitor of nitric oxide synthesis, N(G)-nitro-L-arginine (NOARG). NOARG was infused into the renal artery to yield a renal arterial blood concentration of 0.4 mumol ml-1. NOARG did not change systemic arterial blood pressure and glomerular filtration rate, but reduced basal renal blood flow by 26 +/- 2%. Urine flow, sodium and potassium excretion were reduced after inhibition of renal nitric oxide synthesis. Basal renin release (3 +/- 2 mug AI min-1) was not altered by NOARG infusion (1 +/- 1 mug AI min-1). To stimulate renin release the renal artery was constricted to a renal perfusion pressure of 50 mmHg. At this perfusion pressure infusion of NOARG reduced renin release significantly from 48 +/- 11 mug AI min-1 to 14 +/- 4 mug AI min-1. In conclusion, inhibition of renal nitric oxide synthesis reduces basal renal blood flow and reduces renin release stimulated by renal arterial constriction. These findings indicate that renal nitric oxide modulates both renal blood flow and renin release in vivo.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [31] ENDOTHELIUM-DERIVED NITRIC-OXIDE (EDNO) IS AN IMPORTANT REGULATOR OF RENAL HEMODYNAMICS AND RENIN RELEASE IN THE DEVELOPING PIGLET
    SOLHAUG, MJ
    WALLACE, MR
    GRANGER, JP
    FASEB JOURNAL, 1993, 7 (03): : A405 - A405
  • [32] CARDIOVASCULAR EFFECTS OF A NITRIC-OXIDE RELEASING COMPOUND (NOC-7) IN ANESTHETIZED DOGS
    ZHANG, P
    OHARA, A
    MASHIMO, T
    KOSAKA, H
    YOSHIYA, I
    ANESTHESIOLOGY, 1995, 83 (3A) : A654 - A654
  • [33] CONTROL OF RENAL HEMODYNAMICS DURING INTRARENAL AND SYSTEMIC BLOCKADE OF NITRIC-OXIDE SYNTHESIS IN CONSCIOUS DOGS
    GRANGER, JP
    ALBEROLA, AM
    SALAZAR, FJ
    NAKAMURA, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S160 - S162
  • [34] ROLE OF NITRIC-OXIDE IN CORONARY VASOMOTOR RESPONSES TO ETOMIDATE, PROPOFOL AND THIOPENTAL IN ANESTHETIZED DOGS
    MOORE, PG
    KIEN, ND
    BOLTY, RM
    REITAN, JA
    ANESTHESIOLOGY, 1993, 79 (3A) : A669 - A669
  • [35] IMPLICATION OF NITRIC-OXIDE (NO) IN THE CONTROL OF GASTRIN AND SOMATOSTATIN RELEASE IN CONSCIOUS DOGS
    BILSKI, J
    CIESZKOWSKI, M
    KONTUREK, SJ
    GASTROENTEROLOGY, 1995, 108 (04) : A953 - A953
  • [36] EFFECTS OF SUBSTANCE-P ON RENIN RELEASE AND RENAL-FUNCTION IN ANESTHETIZED DOGS
    GULLNER, HG
    CAMPBELL, WB
    PETTINGER, WA
    LIFE SCIENCES, 1979, 24 (03) : 237 - 245
  • [37] ROLE OF NITRIC-OXIDE (NO) IN HYPEREMIA IN THE ANESTHETIZED DOG
    MCAULIFFE, SAG
    MOORS, JA
    POUCHER, SM
    SNOW, HM
    JOURNAL OF PHYSIOLOGY-LONDON, 1994, 480P : P137 - P138
  • [38] INTRARENAL NITRIC-OXIDE (NO) SYNTHESIS INHIBITION INCREASES RENIN SECRETION RATE
    TABOR, BL
    GODFREY, C
    STRONG, MH
    WILKINS, FC
    GRANGER, JP
    FASEB JOURNAL, 1994, 8 (04): : A579 - A579
  • [39] REGIONAL CORONARY HEMODYNAMIC-EFFECTS OF 2 INHIBITORS OF NITRIC-OXIDE SYNTHESIS IN ANESTHETIZED, OPEN-CHEST DOGS
    RICHARD, V
    BERDEAUX, A
    LAROCHELLE, CD
    GIUDICELLI, JF
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) : 59 - 64
  • [40] INTERACTION BETWEEN NITRIC-OXIDE AND ANGIOTENSIN-II ON ANTIDIURESIS AND NOREPINEPHRINE OVERFLOW INDUCED BY STIMULATION OF RENAL NERVES IN ANESTHETIZED DOGS
    EGI, Y
    MATSUMURA, Y
    MIURA, A
    MURATA, S
    MORIMOTO, S
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (02) : 187 - 193